OS Therapies files prospectus supplement for resale of up to 10.5M shares by selling stockholders

OS Therapies Inc

Filed prospectus supplement covering resale of up to 10,529,417 shares of common stock by selling stockholders.
Shares registered under existing S-3 shelf effective August 12, 2025.
No new shares issued; proceeds go to selling stockholders, not the company.
Legal opinion of Olshan Frome Wolosky LLP on share legality attached as Exhibit 5.1.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.